Axis-Shield, CTT Settle Patent Dispute Over Homocysteine Assays
Under the agreement, Axis-Shield had agreed to pay royalties governing past and future sales of homocysteine tests to CTT until patent expiry in 2007, CTT said.
The agreement covers the distributor sales of Axis-Shield labelled kits, together with the homocysteine kits sold by BioRad in the US.
The negotiated agreement between CTT and Axis-Shield includes payment for past homocysteine tests sold by Axis-Shield...
To view the full article, register now.